Annual D&A:
$2.90M-$417.00K(-12.59%)Summary
- As of today, PTGX annual D&A is $2.90 million, with the most recent change of -$417.00 thousand (-12.59%) on December 31, 2024.
- During the last 3 years, PTGX annual D&A has risen by +$120.00 thousand (+4.32%).
- PTGX annual D&A is now -14.07% below its all-time high of $3.37 million, reached on December 31, 2022.
Performance
PTGX Depreciation & Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly D&A:
$361.00K+$57.00K(+18.75%)Summary
- As of today, PTGX quarterly D&A is $361.00 thousand, with the most recent change of +$57.00 thousand (+18.75%) on September 30, 2025.
- Over the past year, PTGX quarterly D&A has dropped by -$286.00 thousand (-44.20%).
- PTGX quarterly D&A is now -59.53% below its all-time high of $892.00 thousand, reached on June 30, 2024.
Performance
PTGX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$1.44M-$286.00K(-16.57%)Summary
- As of today, PTGX TTM D&A is $1.44 million, with the most recent change of -$286.00 thousand (-16.57%) on September 30, 2025.
- Over the past year, PTGX TTM D&A has dropped by -$1.75 million (-54.87%).
- PTGX TTM D&A is now -57.28% below its all-time high of $3.37 million, reached on June 30, 2024.
Performance
PTGX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
PTGX Depreciation & Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -12.6% | -44.2% | -54.9% |
| 3Y3 Years | +4.3% | -57.7% | -57.0% |
| 5Y5 Years | +14.7% | -42.3% | -32.5% |
PTGX Depreciation & Amortization Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -14.1% | +4.3% | -59.5% | +124.2% | -57.3% | +46.2% |
| 5Y | 5-Year | -14.1% | +14.7% | -59.5% | +124.2% | -57.3% | +95.9% |
| All-Time | All-Time | -14.1% | +1072.1% | -59.5% | +124.2% | -57.3% | +2382.8% |
PTGX Depreciation & Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $361.00K(+18.8%) | $1.44M(-16.6%) |
| Jun 2025 | - | $304.00K(+27.2%) | $1.73M(-25.4%) |
| Mar 2025 | - | $239.00K(-55.4%) | $2.31M(-20.1%) |
| Dec 2024 | $2.90M(-12.6%) | $536.00K(-17.2%) | $2.90M(-9.3%) |
| Sep 2024 | - | $647.00K(-27.5%) | $3.19M(-5.3%) |
| Jun 2024 | - | $892.00K(+8.8%) | $3.37M(+2.2%) |
| Mar 2024 | - | $820.00K(-1.4%) | $3.30M(-0.4%) |
| Dec 2023 | $3.31M(-1.7%) | $832.00K(+0.6%) | $3.31M(+236.2%) |
| Sep 2023 | - | $827.00K(+0.7%) | $985.00K(-2.6%) |
| Jun 2023 | - | $821.00K(-1.3%) | $1.01M(-2.1%) |
| Mar 2023 | - | $832.00K(+155.7%) | $1.03M(-0.1%) |
| Dec 2022 | $3.37M(+21.4%) | -$1.50M(-275.3%) | $1.03M(-69.1%) |
| Sep 2022 | - | $853.00K(+1.2%) | $3.35M(+4.7%) |
| Jun 2022 | - | $843.00K(+1.2%) | $3.20M(+7.2%) |
| Mar 2022 | - | $833.00K(+1.7%) | $2.98M(+7.5%) |
| Dec 2021 | $2.77M(+1.9%) | $819.00K(+16.3%) | $2.77M(+241.3%) |
| Sep 2021 | - | $704.00K(+12.1%) | $813.00K(+10.6%) |
| Jun 2021 | - | $628.00K(+0.6%) | $735.00K(-2.3%) |
| Mar 2021 | - | $624.00K(+154.6%) | $752.00K(-4.7%) |
| Dec 2020 | $2.72M | -$1.14M(-282.6%) | $789.00K(-63.0%) |
| Sep 2020 | - | $626.00K(-2.9%) | $2.13M(+25.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $645.00K(-2.4%) | $1.70M(+38.0%) |
| Mar 2020 | - | $661.00K(+227.2%) | $1.23M(+75.5%) |
| Dec 2019 | $2.52M(+378.9%) | $202.00K(+3.6%) | $703.00K(+11.8%) |
| Sep 2019 | - | $195.00K(+10.8%) | $629.00K(+7.5%) |
| Jun 2019 | - | $176.00K(+35.4%) | $585.00K(+1.0%) |
| Mar 2019 | - | $130.00K(+1.6%) | $579.00K(+9.9%) |
| Dec 2018 | $527.00K(+29.8%) | $128.00K(-15.2%) | $527.00K(+2.1%) |
| Sep 2018 | - | $151.00K(-11.2%) | $516.00K(+9.1%) |
| Jun 2018 | - | $170.00K(+117.9%) | $473.00K(+19.4%) |
| Mar 2018 | - | $78.00K(-33.3%) | $396.00K(-2.5%) |
| Dec 2017 | $406.00K(+28.1%) | $117.00K(+8.3%) | $406.00K(+11.5%) |
| Sep 2017 | - | $108.00K(+16.1%) | $364.00K(+7.4%) |
| Jun 2017 | - | $93.00K(+5.7%) | $339.00K(+2.1%) |
| Mar 2017 | - | $88.00K(+17.3%) | $332.00K(+4.7%) |
| Dec 2016 | $317.00K(+28.3%) | $75.00K(-9.6%) | $317.00K(+31.0%) |
| Sep 2016 | - | $83.00K(-3.5%) | $242.00K(+52.2%) |
| Jun 2016 | - | $86.00K(+17.8%) | $159.00K(+117.8%) |
| Mar 2016 | - | $73.00K(+25.9%) | $73.00K(+25.9%) |
| Dec 2015 | $247.00K(-4.3%) | - | - |
| Mar 2015 | - | $58.00K | $58.00K |
| Dec 2014 | $258.00K | - | - |
FAQ
- What is Protagonist Therapeutics, Inc. annual D&A?
- What is the all-time high annual D&A for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. annual D&A year-on-year change?
- What is Protagonist Therapeutics, Inc. quarterly D&A?
- What is the all-time high quarterly D&A for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. quarterly D&A year-on-year change?
- What is Protagonist Therapeutics, Inc. TTM D&A?
- What is the all-time high TTM D&A for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. TTM D&A year-on-year change?
What is Protagonist Therapeutics, Inc. annual D&A?
The current annual D&A of PTGX is $2.90M
What is the all-time high annual D&A for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high annual D&A is $3.37M
What is Protagonist Therapeutics, Inc. annual D&A year-on-year change?
Over the past year, PTGX annual D&A has changed by -$417.00K (-12.59%)
What is Protagonist Therapeutics, Inc. quarterly D&A?
The current quarterly D&A of PTGX is $361.00K
What is the all-time high quarterly D&A for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high quarterly D&A is $892.00K
What is Protagonist Therapeutics, Inc. quarterly D&A year-on-year change?
Over the past year, PTGX quarterly D&A has changed by -$286.00K (-44.20%)
What is Protagonist Therapeutics, Inc. TTM D&A?
The current TTM D&A of PTGX is $1.44M
What is the all-time high TTM D&A for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high TTM D&A is $3.37M
What is Protagonist Therapeutics, Inc. TTM D&A year-on-year change?
Over the past year, PTGX TTM D&A has changed by -$1.75M (-54.87%)